Insider Cluster (4 insiders) ·Filed Jun 15, 2026

ORKA

Oruka Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 4 insiders, $1.1M total
Actionable Insight • Neutral

Insider sales are negligible relative to market cap and likely reflect routine portfolio diversification. No actionable signal for traders.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
ORKA ▲ +35.36% at T+60d
NEUTRAL call ✓ call won +35.36% · α vs SPY +34.36% · entry $67.71 → $91.65
Entry anchored
Jun 15, 03:59 PM ET
via exchange tick
T+1d
+4.68%
call +4.68% · α +5.93%
$70.88
settled 4mo ago
T+5d
+23.17%
call +23.17% · α +25.40%
$83.40
settled 3mo ago
T+20d
+29.18%
call +29.18% · α +28.98%
$87.47
settled 3mo ago
T+60d
+35.36%
call +35.36% · α +34.36%
$91.65
settled 22d ago

Price Chart

Loading chart...

Executive Summary

Four Oruka Therapeutics insiders (CEO, COO, General Counsel, and a Director) sold a total of ~$2.67M in open-market transactions over a 5-day window. The sales represent only 0.06% of the company's $4.2B market cap, making them immaterial and likely routine portfolio diversification.

Key Financial Metrics

Direction
selling
Total Value
$2.7M
Insiders
4

Key Facts

  • CEO Lawrence Klein sold 1,729 shares for ~$120K on June 15.
  • COO Laura Sandler sold 600 shares for ~$42K on June 15.
  • General Counsel Paul Quinlan sold 733 shares for ~$51K on June 15.
  • Director Carl Dambkowski sold 35,000 shares (two transactions) for ~$2.45M on June 11-12.
  • Total insider sales of ~$2.67M are 0.06% of ORKA's $4.2B market cap.

Financial Impact

Total insider sales of $2.67M represent 0.06% of market cap, immaterial.

insider selling

Risk Factors

  • No material risk from this cluster; sales are too small to indicate a bearish view.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ORKA-1781564045890
26 reports for ORKA
Performance horizon
100% Hit rate 11 of 11 directional calls best @ T+60▲ +80.05%Jun 1, 2026
Filters
Rows
Reports for ORKA — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
Insider Cluster
NEUTRAL ★ 3/10
$93.55 $89.93▼ −3.87%▼ −6.44%$84.38 (−9.80%)
Sep 1, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$91.63 $91.65▼ −0.02%▼ −0.98%$84.38 (+7.91%)
Aug 28, 2026
5w ago
EFFECT
BEARISH ★ 6/10
$91.15 $92.51▼ −1.50%▼ −1.39%$84.38 (+7.42%)
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.08 $101.82▼ −9.96%▼ −9.76%$84.38 (−25.38%)
Aug 10, 2026
7w ago
Press Release
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Aug 10, 2026
7w ago
8-K
BULLISH ★ 6/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Jul 15, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$83.04 $91.95▲ +10.73%▲ +12.40%$84.38 (+1.61%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 5/10
$85.21 $88.27▲ +3.59%▲ +2.66%$84.38 (−0.97%)
Jun 22, 2026
14w ago
Insider Cluster
NEUTRAL ★ 3/10
$83.40 $92.49▲ +10.90%▲ +9.89%$84.38 (+1.18%)
Showing 10 of 26

US Market Status

Market Open — Closes in 3h 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 15, 2026